Related Experiment Videos
Penicillamine-induced ocular myasthenia gravis
American Journal of Ophthalmology
|January 15, 1985
Summary
Two rheumatoid arthritis patients developed reversible ocular myasthenia gravis after penicillamine treatment. Their HLA-DR1 antigen differed from typical idiopathic myasthenia gravis patients, suggesting distinct genetic links. Symptoms resolved upon drug cessation.
Area of Science:
- Rheumatology
- Neurology
- Immunogenetics
Background:
- Rheumatoid arthritis is a chronic autoimmune disease.
- Myasthenia gravis is a neuromuscular autoimmune disorder.
- Penicillamine is a medication sometimes used for rheumatoid arthritis.